Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for EFFIENT
- Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm
- Prasugrel 5 mg vs. Ticagrelor 60 mg in CHIP (E5TION)
- Pharmacodynamic and Pharmacokinetic of Switching From Cangrelor to Prasugrel in ACS Patients Undergoing PCI
- GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
- Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
- SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
- Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
- Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation Study
- A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
- Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
- Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting
- Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor
- Ticagrelor vs. Prasugrel Effects on Infarct Size
- Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
- Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting
- Pharmacokinetics of Antiplatelet Drugs in Diabetic pAtients
- Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate
- Pharmacological Effects of Crushing Prasugrel in STEMI Patients
- A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:
- Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor
- Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in Diabetes
- Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery Disease
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD)
- Effect of Prasugrel Versus Clopidogrel on Platelet Function After Bivalirudin Cessation
- A Study of Prasugrel in Healthy Participants
- PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants
- Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention
- Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin)
- Study of Prasugrel in Korean Healthy Male Volunteers
- Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease
- Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease
- Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
- Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
- Early Thienopyridine Treatment to Improve Primary PCI in Patients With Acute MI
- The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease
- An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adults
- Prasugrel Versus Placebo in Adult Sickle Cell Disease
- Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery Disease
- Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery Disease
- A Comparison of Prasugrel at PCI or Time of Diagnosis of Non-ST Elevation Myocardial Infarction
- Prasugrel/Clopidogrel Maintenance Dose Washout Study
- Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel (TRIGGER-PCI)
- A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome
- A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects
- Third Optimizing Anti-Platelet Therapy in Diabetes MellitUS (OPTIMUS-3)
- The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)
- Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting
- Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event
- A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention
- A Trial of CS-747 (Prasugrel) Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Clinical trials list
click for details